Share Price and Basic Stock Data
Last Updated: July 26, 2025, 2:55 pm
| PEG Ratio | 0.52 |
|---|
Quick Insight
Mysore Petro Chemicals Ltd, trading at ₹124 with a market capitalization of ₹81.6 crore, presents an intriguing investment opportunity, particularly given its low price-to-earnings (P/E) ratio of 5.88, which suggests that the stock may be undervalued compared to its peers in the organic chemicals sector. Despite a return on equity (ROE) of 6.29% and return on capital employed (ROCE) of 7.90%, the company's financials lack transparency, as key figures such as net profit and borrowings are not available. With promoters holding a significant 72.99% stake and foreign institutional investors (FIIs) at 3.03%, the stock indicates a stable shareholder structure. However, the absence of detailed financial metrics raises concerns about the company's operational efficiency. Investors should proceed with caution, focusing on future disclosures to better assess potential risks and rewards in this niche market.
Competitors of Mysore Petro Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mysore Petro Chemicals Ltd | 81.8 Cr. | 124 | 262/117 | 28.6 | 335 | 1.61 % | 7.82 % | 1.30 % | 10.0 |
| I G Petrochemicals Ltd | 1,490 Cr. | 484 | 727/361 | 13.6 | 431 | 2.07 % | 11.4 % | 8.53 % | 10.0 |
| Industry Average | 1,490.00 Cr | 304.00 | 21.10 | 383.00 | 1.84% | 9.61% | 4.92% | 10.00 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.02 | 1.45 | 8.33 | 2.18 | 6.46 | 0.00 | 7.08 | 5.79 | 15.18 | 13.89 | 9.16 | 6.39 | 7.44 |
| Expenses | 5.80 | 3.71 | 8.99 | 3.76 | 10.65 | 1.54 | 7.78 | 8.69 | 18.92 | 18.44 | 10.64 | 7.59 | 8.04 |
| Operating Profit | -0.78 | -2.26 | -0.66 | -1.58 | -4.19 | -1.54 | -0.70 | -2.90 | -3.74 | -4.55 | -1.48 | -1.20 | -0.60 |
| OPM % | -15.54% | -155.86% | -7.92% | -72.48% | -64.86% | -9.89% | -50.09% | -24.64% | -32.76% | -16.16% | -18.78% | -8.06% | |
| Other Income | 13.53 | 11.95 | 8.64 | 6.60 | 9.42 | 8.72 | 3.07 | 3.03 | 4.48 | 19.59 | 0.38 | -7.80 | 4.01 |
| Interest | 0.07 | 0.12 | 0.19 | 0.12 | 0.16 | 0.04 | 0.01 | 0.03 | 0.20 | 0.40 | 0.02 | 0.02 | 0.02 |
| Depreciation | 0.15 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.46 | 1.00 | 0.09 | 0.09 | 0.09 |
| Profit before tax | 12.53 | 9.46 | 7.68 | 4.79 | 4.96 | 7.03 | 2.25 | -0.01 | 0.08 | 13.64 | -1.21 | -9.11 | 3.30 |
| Tax % | 23.06% | 25.05% | 17.19% | 18.58% | 32.06% | 25.60% | -3.11% | 200.00% | 925.00% | 35.78% | 107.44% | -31.83% | 31.52% |
| Net Profit | 9.64 | 7.08 | 6.37 | 3.90 | 3.37 | 5.23 | 2.32 | -0.03 | -0.67 | 8.75 | -2.51 | -6.21 | 2.26 |
| EPS in Rs | 14.64 | 10.75 | 9.68 | 5.92 | 5.12 | 7.94 | 3.52 | -0.05 | -0.08 | 14.43 | -3.81 | -9.43 | 3.43 |
Last Updated: May 31, 2025, 5:36 am
Below is a detailed analysis of the quarterly data for Mysore Petro Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 7.44 Cr.. The value appears strong and on an upward trend. It has increased from 6.39 Cr. (Dec 2024) to 7.44 Cr., marking an increase of 1.05 Cr..
- For Expenses, as of Mar 2025, the value is 8.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.59 Cr. (Dec 2024) to 8.04 Cr., marking an increase of 0.45 Cr..
- For Operating Profit, as of Mar 2025, the value is -0.60 Cr.. The value appears strong and on an upward trend. It has increased from -1.20 Cr. (Dec 2024) to -0.60 Cr., marking an increase of 0.60 Cr..
- For OPM %, as of Mar 2025, the value is -8.06%. The value appears strong and on an upward trend. It has increased from -18.78% (Dec 2024) to -8.06%, marking an increase of 10.72%.
- For Other Income, as of Mar 2025, the value is 4.01 Cr.. The value appears strong and on an upward trend. It has increased from -7.80 Cr. (Dec 2024) to 4.01 Cr., marking an increase of 11.81 Cr..
- For Interest, as of Mar 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.02 Cr..
- For Depreciation, as of Mar 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.09 Cr..
- For Profit before tax, as of Mar 2025, the value is 3.30 Cr.. The value appears strong and on an upward trend. It has increased from -9.11 Cr. (Dec 2024) to 3.30 Cr., marking an increase of 12.41 Cr..
- For Tax %, as of Mar 2025, the value is 31.52%. The value appears to be increasing, which may not be favorable. It has increased from -31.83% (Dec 2024) to 31.52%, marking an increase of 63.35%.
- For Net Profit, as of Mar 2025, the value is 2.26 Cr.. The value appears strong and on an upward trend. It has increased from -6.21 Cr. (Dec 2024) to 2.26 Cr., marking an increase of 8.47 Cr..
- For EPS in Rs, as of Mar 2025, the value is 3.43. The value appears strong and on an upward trend. It has increased from -9.43 (Dec 2024) to 3.43, marking an increase of 12.86.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 12:45 pm
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.30 | 6.23 | 32.58 | 12.98 | 22.84 | 20.90 | 18.41 | 28.05 | 33.48 |
| Expenses | 24.60 | 9.79 | 35.95 | 15.53 | 24.98 | 23.65 | 25.55 | 34.90 | 39.07 |
| Operating Profit | 5.70 | -3.56 | -3.37 | -2.55 | -2.14 | -2.75 | -7.14 | -6.85 | -5.59 |
| OPM % | 18.81% | -57.14% | -10.34% | -19.65% | -9.37% | -13.16% | -38.78% | -24.42% | -16.70% |
| Other Income | 13.98 | 93.03 | 22.59 | 8.64 | 27.00 | 46.19 | 35.05 | 17.28 | 13.39 |
| Interest | 1.20 | 0.07 | 0.04 | 0.06 | 0.34 | 0.26 | 0.58 | 0.29 | 0.07 |
| Depreciation | 2.93 | 0.78 | 0.68 | 0.63 | 0.60 | 0.59 | 0.43 | 0.80 | 0.37 |
| Profit before tax | 15.55 | 88.62 | 18.50 | 5.40 | 23.92 | 42.59 | 26.90 | 9.34 | 7.36 |
| Tax % | 5.59% | 19.15% | 4.00% | 10.00% | 109.32% | 23.24% | 22.97% | 26.66% | 58.70% |
| Net Profit | 14.68 | 71.65 | 17.76 | 4.86 | -2.24 | 32.69 | 20.72 | 6.85 | 3.04 |
| EPS in Rs | 22.30 | 108.83 | 26.98 | 7.38 | -3.40 | 49.65 | 31.47 | 11.35 | 4.62 |
| Dividend Payout % | 4.49% | 1.84% | 7.42% | 27.12% | -58.84% | 5.04% | 7.95% | 22.05% | 43.36% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 388.08% | -75.21% | -72.64% | -146.09% | 1559.38% | -36.62% | -66.94% | -55.62% |
| Change in YoY Net Profit Growth (%) | 0.00% | -463.29% | 2.58% | -73.46% | 1705.47% | -1595.99% | -30.32% | 11.32% |
Mysore Petro Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 17% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -55% |
| TTM: | -56% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 22% |
| 3 Years: | 6% |
| 1 Year: | -37% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 4% |
| Last Year: | 1% |
Last Updated: Unknown
Balance Sheet
Last Updated: July 25, 2025, 1:02 pm
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 |
| Reserves | 69.65 | 140.67 | 156.89 | 160.12 | 156.67 | 187.98 | 207.09 | 213.66 | 214.10 |
| Borrowings | 6.17 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.31 | 0.22 |
| Other Liabilities | 10.47 | 4.66 | 5.97 | 6.11 | 30.88 | 39.59 | 44.64 | 63.60 | 52.03 |
| Total Liabilities | 92.88 | 152.24 | 169.45 | 172.82 | 194.14 | 234.16 | 258.32 | 304.16 | 272.94 |
| Fixed Assets | 32.50 | 18.83 | 16.30 | 15.67 | 15.07 | 15.77 | 15.34 | 47.51 | 14.50 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 2.02 | 0.00 |
| Investments | 53.95 | 79.42 | 107.18 | 115.48 | 144.94 | 213.33 | 227.90 | 231.64 | 241.55 |
| Other Assets | 6.43 | 53.99 | 45.97 | 41.67 | 34.13 | 5.06 | 14.78 | 22.99 | 16.89 |
| Total Assets | 92.88 | 152.24 | 169.45 | 172.82 | 194.14 | 234.16 | 258.32 | 304.16 | 272.94 |
Below is a detailed analysis of the balance sheet data for Mysore Petro Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 6.59 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.59 Cr..
- For Reserves, as of Mar 2025, the value is 214.10 Cr.. The value appears strong and on an upward trend. It has increased from 213.66 Cr. (Mar 2024) to 214.10 Cr., marking an increase of 0.44 Cr..
- For Borrowings, as of Mar 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 20.31 Cr. (Mar 2024) to 0.22 Cr., marking a decrease of 20.09 Cr..
- For Other Liabilities, as of Mar 2025, the value is 52.03 Cr.. The value appears to be improving (decreasing). It has decreased from 63.60 Cr. (Mar 2024) to 52.03 Cr., marking a decrease of 11.57 Cr..
- For Total Liabilities, as of Mar 2025, the value is 272.94 Cr.. The value appears to be improving (decreasing). It has decreased from 304.16 Cr. (Mar 2024) to 272.94 Cr., marking a decrease of 31.22 Cr..
- For Fixed Assets, as of Mar 2025, the value is 14.50 Cr.. The value appears to be declining and may need further review. It has decreased from 47.51 Cr. (Mar 2024) to 14.50 Cr., marking a decrease of 33.01 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.02 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.02 Cr..
- For Investments, as of Mar 2025, the value is 241.55 Cr.. The value appears strong and on an upward trend. It has increased from 231.64 Cr. (Mar 2024) to 241.55 Cr., marking an increase of 9.91 Cr..
- For Other Assets, as of Mar 2025, the value is 16.89 Cr.. The value appears to be declining and may need further review. It has decreased from 22.99 Cr. (Mar 2024) to 16.89 Cr., marking a decrease of 6.10 Cr..
- For Total Assets, as of Mar 2025, the value is 272.94 Cr.. The value appears to be declining and may need further review. It has decreased from 304.16 Cr. (Mar 2024) to 272.94 Cr., marking a decrease of 31.22 Cr..
Notably, the Reserves (214.10 Cr.) exceed the Borrowings (0.22 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.47 | -3.88 | -3.37 | -2.55 | -2.14 | -2.75 | -7.14 | -27.16 | -5.81 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19.76 | 0.00 | 4.37 | 20.53 | 77.67 | 29.34 | 104.09 | 126.74 | 86.45 |
| Inventory Days | 146.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.93 | 0.00 |
| Days Payable | 149.60 | 24.12 | |||||||
| Cash Conversion Cycle | 16.99 | 0.00 | 4.37 | 20.53 | 77.67 | 29.34 | 104.09 | 127.56 | 86.45 |
| Working Capital Days | -45.66 | 642.12 | 138.92 | 410.84 | 290.37 | -6.46 | 81.88 | -51.40 | 162.88 |
| ROCE % | 20.91% | 11.47% | 3.12% | 18.92% | 23.58% | 12.26% | 3.67% | 7.90% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.62 | 11.35 | 31.48 | 49.66 | -3.41 |
| Diluted EPS (Rs.) | 4.62 | 11.35 | 31.48 | 49.66 | -3.41 |
| Cash EPS (Rs.) | -16.65 | 3.67 | -8.06 | -2.59 | -29.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 335.00 | 337.31 | 324.36 | 295.36 | 247.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 335.00 | 337.31 | 324.36 | 295.36 | 247.83 |
| Revenue From Operations / Share (Rs.) | 50.82 | 42.58 | 27.95 | 31.73 | 34.67 |
| PBDIT / Share (Rs.) | 6.53 | 7.88 | 2.20 | 12.82 | -0.04 |
| PBIT / Share (Rs.) | 5.97 | 6.67 | 1.55 | 11.92 | -0.95 |
| PBT / Share (Rs.) | 6.20 | 6.24 | 0.66 | 11.53 | -1.48 |
| Net Profit / Share (Rs.) | -17.21 | 2.46 | -8.71 | -3.49 | -41.18 |
| NP After MI And SOA / Share (Rs.) | 4.62 | 11.34 | 31.45 | 49.63 | -3.40 |
| PBDIT Margin (%) | 12.85 | 18.51 | 7.87 | 40.41 | -0.13 |
| PBIT Margin (%) | 11.75 | 15.66 | 5.55 | 37.56 | -2.76 |
| PBT Margin (%) | 12.19 | 14.64 | 2.38 | 36.34 | -4.25 |
| Net Profit Margin (%) | -33.86 | 5.77 | -31.17 | -11.01 | -118.78 |
| NP After MI And SOA Margin (%) | 9.09 | 26.63 | 112.53 | 156.42 | -9.82 |
| Return on Networth / Equity (%) | 1.37 | 3.39 | 9.69 | 16.80 | -1.37 |
| Return on Capital Employeed (%) | 1.47 | 1.55 | 0.40 | 3.39 | -0.33 |
| Return On Assets (%) | 1.11 | 2.45 | 8.02 | 13.96 | -1.15 |
| Asset Turnover Ratio (%) | 0.11 | 0.09 | 0.10 | 0.14 | 0.17 |
| Current Ratio (X) | 3.98 | 1.41 | 13.06 | 7.26 | 8.24 |
| Quick Ratio (X) | 3.98 | 1.33 | 13.06 | 7.26 | 8.24 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 22.02 | 7.94 | 4.02 | -58.68 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 19.89 | 7.78 | 3.95 | 24.82 |
| Earning Retention Ratio (%) | 0.00 | 77.98 | 92.06 | 95.98 | 158.68 |
| Cash Earning Retention Ratio (%) | 0.00 | 80.11 | 92.22 | 96.05 | 75.18 |
| Interest Coverage Ratio (X) | 62.63 | 18.20 | 2.49 | 32.94 | -0.08 |
| Interest Coverage Ratio (Post Tax) (X) | -5.62 | 6.68 | -8.84 | -7.98 | -78.58 |
| Enterprise Value (Cr.) | 75.36 | 112.03 | 65.88 | 67.57 | 47.69 |
| EV / Net Operating Revenue (X) | 2.25 | 3.99 | 3.58 | 3.23 | 2.09 |
| EV / EBITDA (X) | 17.51 | 21.57 | 45.45 | 8.00 | -1563.51 |
| MarketCap / Net Operating Revenue (X) | 2.44 | 4.13 | 3.97 | 3.28 | 2.17 |
| Retention Ratios (%) | 0.00 | 77.97 | 92.05 | 95.97 | 158.68 |
| Price / BV (X) | 0.37 | 0.52 | 0.34 | 0.35 | 0.30 |
| Price / Net Operating Revenue (X) | 2.44 | 4.13 | 3.97 | 3.28 | 2.17 |
| EarningsYield | 0.03 | 0.06 | 0.28 | 0.47 | -0.04 |
After reviewing the key financial ratios for Mysore Petro Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.62. This value is below the healthy minimum of 5. It has decreased from 11.35 (Mar 24) to 4.62, marking a decrease of 6.73.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.62. This value is below the healthy minimum of 5. It has decreased from 11.35 (Mar 24) to 4.62, marking a decrease of 6.73.
- For Cash EPS (Rs.), as of Mar 25, the value is -16.65. This value is below the healthy minimum of 3. It has decreased from 3.67 (Mar 24) to -16.65, marking a decrease of 20.32.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 335.00. It has decreased from 337.31 (Mar 24) to 335.00, marking a decrease of 2.31.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 335.00. It has decreased from 337.31 (Mar 24) to 335.00, marking a decrease of 2.31.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 50.82. It has increased from 42.58 (Mar 24) to 50.82, marking an increase of 8.24.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.53. This value is within the healthy range. It has decreased from 7.88 (Mar 24) to 6.53, marking a decrease of 1.35.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.97. This value is within the healthy range. It has decreased from 6.67 (Mar 24) to 5.97, marking a decrease of 0.70.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.20. This value is within the healthy range. It has decreased from 6.24 (Mar 24) to 6.20, marking a decrease of 0.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -17.21. This value is below the healthy minimum of 2. It has decreased from 2.46 (Mar 24) to -17.21, marking a decrease of 19.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.62. This value is within the healthy range. It has decreased from 11.34 (Mar 24) to 4.62, marking a decrease of 6.72.
- For PBDIT Margin (%), as of Mar 25, the value is 12.85. This value is within the healthy range. It has decreased from 18.51 (Mar 24) to 12.85, marking a decrease of 5.66.
- For PBIT Margin (%), as of Mar 25, the value is 11.75. This value is within the healthy range. It has decreased from 15.66 (Mar 24) to 11.75, marking a decrease of 3.91.
- For PBT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has decreased from 14.64 (Mar 24) to 12.19, marking a decrease of 2.45.
- For Net Profit Margin (%), as of Mar 25, the value is -33.86. This value is below the healthy minimum of 5. It has decreased from 5.77 (Mar 24) to -33.86, marking a decrease of 39.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.09. This value is within the healthy range. It has decreased from 26.63 (Mar 24) to 9.09, marking a decrease of 17.54.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 15. It has decreased from 3.39 (Mar 24) to 1.37, marking a decrease of 2.02.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 10. It has decreased from 1.55 (Mar 24) to 1.47, marking a decrease of 0.08.
- For Return On Assets (%), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 5. It has decreased from 2.45 (Mar 24) to 1.11, marking a decrease of 1.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.11. It has increased from 0.09 (Mar 24) to 0.11, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.98. This value exceeds the healthy maximum of 3. It has increased from 1.41 (Mar 24) to 3.98, marking an increase of 2.57.
- For Quick Ratio (X), as of Mar 25, the value is 3.98. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 3.98, marking an increase of 2.65.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 22.02 (Mar 24) to 0.00, marking a decrease of 22.02.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 19.89 (Mar 24) to 0.00, marking a decrease of 19.89.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 77.98 (Mar 24) to 0.00, marking a decrease of 77.98.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 80.11 (Mar 24) to 0.00, marking a decrease of 80.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 62.63. This value is within the healthy range. It has increased from 18.20 (Mar 24) to 62.63, marking an increase of 44.43.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -5.62. This value is below the healthy minimum of 3. It has decreased from 6.68 (Mar 24) to -5.62, marking a decrease of 12.30.
- For Enterprise Value (Cr.), as of Mar 25, the value is 75.36. It has decreased from 112.03 (Mar 24) to 75.36, marking a decrease of 36.67.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.25. This value is within the healthy range. It has decreased from 3.99 (Mar 24) to 2.25, marking a decrease of 1.74.
- For EV / EBITDA (X), as of Mar 25, the value is 17.51. This value exceeds the healthy maximum of 15. It has decreased from 21.57 (Mar 24) to 17.51, marking a decrease of 4.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 4.13 (Mar 24) to 2.44, marking a decrease of 1.69.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 77.97 (Mar 24) to 0.00, marking a decrease of 77.97.
- For Price / BV (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.52 (Mar 24) to 0.37, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 4.13 (Mar 24) to 2.44, marking a decrease of 1.69.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mysore Petro Chemicals Ltd:
- Net Profit Margin: -33.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.47% (Industry Average ROCE: 9.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.37% (Industry Average ROE: 4.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -5.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.6 (Industry average Stock P/E: 21.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -33.86%
About the Company - Qualitative Analysis
Mysore Petro Chemicals Ltd. is a Public Limited Listed company incorporated on 09/06/1969 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L24221KA1969PLC001799 and registration number is 001799. Currently Company is involved in the business activities of Other specialized wholesale. Company's Total Operating Revenue is Rs. 33.48 Cr. and Equity Capital is Rs. 6.59 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Maleic Anhydride | D/4, Jyothi Complex, 134/1, Infantry Road, Bengaluru Karnataka 560001 | mpcl@mysorepetro.com http://www.mysorepetro.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Vaijayanti Pandit | Chairperson & Independent Director |
| Mr. Nikunj Dhanuka | Non Executive Director |
| Mr. Mayank Dhanuka | Non Executive Director |
| Mr. Satyanarayan Bankatlal Maheshwari | Executive Director |
| Mr. Shanti Kumar Loonker | Independent Director |
| Mrs. Uma Acharya | Independent Director |
FAQ
What is the intrinsic value of Mysore Petro Chemicals Ltd?
Mysore Petro Chemicals Ltd's intrinsic value (as of 27 July 2025) is 101.25 18.35% lower the current market price of 124.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 81.8 Cr. market cap, FY2025-2026 high/low of 262/117, reserves of 214.10 Cr, and liabilities of 272.94 Cr.
What is the Market Cap of Mysore Petro Chemicals Ltd?
The Market Cap of Mysore Petro Chemicals Ltd is 81.8 Cr..
What is the current Stock Price of Mysore Petro Chemicals Ltd as on 27 July 2025?
The current stock price of Mysore Petro Chemicals Ltd as on 27 July 2025 is 124.
What is the High / Low of Mysore Petro Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mysore Petro Chemicals Ltd stocks is ₹262/117.
What is the Stock P/E of Mysore Petro Chemicals Ltd?
The Stock P/E of Mysore Petro Chemicals Ltd is 28.6.
What is the Book Value of Mysore Petro Chemicals Ltd?
The Book Value of Mysore Petro Chemicals Ltd is 335.
What is the Dividend Yield of Mysore Petro Chemicals Ltd?
The Dividend Yield of Mysore Petro Chemicals Ltd is 1.61 %.
What is the ROCE of Mysore Petro Chemicals Ltd?
The ROCE of Mysore Petro Chemicals Ltd is 7.82 %.
What is the ROE of Mysore Petro Chemicals Ltd?
The ROE of Mysore Petro Chemicals Ltd is 1.30 %.
What is the Face Value of Mysore Petro Chemicals Ltd?
The Face Value of Mysore Petro Chemicals Ltd is 10.0.